RIPK1 and colitis: Blocking RIPK1 by Nec-1s in vivo (DSS-induced colitis in mice) and in vitro (TNF-α induced inflammation in the IEC cell line) dramatically alleviated the colitis and cell death which shares the same phenotype with ABIN1 overexpression.